eli lilly retatrutide trials Investigating the “efficacy and safety of retatrutide”, saw "clinically meaningful weight loss” in a phase three clinical trial ㅤ Go to the C+D website through the link 🔗in the bio Starting Phase 3b Clinical Trial

Published peer-reviewed research on this compound is indexed on PubMed under both the chemical name "Retatrutide" and the developmental code "LY3437943"

The difference now is that instead of detox teas or appetite suppressants, the product promoted is a prescription medication that alters the bodys metabolic system

But the weight loss achieved without training is fundamentally different from weight loss with training

** Based on the treatment policy estimand: treatment effect regardless of if patients stayed on treatment or took other weight loss therapies

The GLP-1 Gold Rush GLP-1 receptor agonists have quickly become some of the most profitable drugs in pharmaceutical history